EyePoint Pharmaceuticals Inc. buy Citigroup Inc.
Start price
09.03.26
/
50%
€13.50
Target price
09.03.27
€30.36
Performance (%)
-20.71%
Price
08:55
?
Summary
This prediction is currently active. The price of EyePoint Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.71%. This prediction currently runs until 09.03.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| EyePoint Pharmaceuticals Inc. | -5.769% | -5.769% |
| iShares Core DAX® | -2.796% | -1.396% |
| iShares Nasdaq 100 | -6.352% | -0.407% |
| iShares Nikkei 225® | -6.943% | -0.275% |
| iShares S&P 500 | -3.410% | 0.396% |
Comments by Citigroup_Inc_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (EYPT) had its price target raised by Citigroup Inc. from $31.00 to $35.00. They now have a "buy" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.89
07.01.25
07.01.25
€31.74
07.01.26
07.01.26
63.26%
08.01.26
08.01.26
